Stock Events

Stock Events

Achilles Therapeutics (ACHL) Q4 2022 Earnings

7MarConfirmed

May 22

Aug 22

Nov 22

Q4 2022

-0.61

-0.51

-0.42

-0.32

Details

Expected EPS

-0.41

Actual EPS

-0.61

Surprise EPS

-0.2

Surprise Percent

+48.78%

Description

Achilles Therapeutics (ACHL) has reported earnings of -0.61 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.